T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
March
31,
2026
Unaudited
1
Portfolio
of
Investments
Par/Shares
$
Value
(Cost
and
value
in
$000s)
BANK
LOANS
 12.6%
(1)
AmWINS
Group,
FRN
1M
TSFR
+
2.00%,
5.668%,
1/30/32 
865,574‌
859‌
Applied
Systems,
FRN
3M
TSFR
+
2.25%,
5.95%,
2/24/31 
6,763,521‌
6,625‌
Applied
Systems,
FRN
3M
TSFR
+
4.50%,
8.20%,
2/23/32 (2)
1,309,000‌
1,289‌
Ascend
Learning,
FRN
1M
TSFR
+
3.00%,
6.668%,
12/11/28 
170,151‌
166‌
Broadstreet
Partners,
FRN
1M
TSFR
+
2.50%,
6.168%,
6/13/31 
3,225,099‌
3,142‌
CPI
Holdco
B,
FRN
1M
TSFR
+
2.00%,
5.668%,
5/17/31 
1,441,011‌
1,430‌
Ellucian
Holdings,
FRN
1M
TSFR
+
2.50%,
6.168%,
10/8/29 (2)
1,744,867‌
1,694‌
Epicor
Software,
FRN
1M
TSFR
+
2.50%,
6.168%,
5/30/31 
1,186,237‌
1,162‌
Filtration
Group,
FRN
1M
TSFR
+
2.50%,
6.168%,
10/21/28 
4,923,366‌
4,921‌
Hilton
Domestic
Operating,
FRN
1M
TSFR
+
1.75%,
5.429%,
11/8/30 
5,022,000‌
5,028‌
HUB
International,
FRN
3M
TSFR
+
2.25%,
5.92%,
6/20/30 
2,783,548‌
2,775‌
ICON
Luxembourg,
FRN
3M
TSFR
+
2.00%,
5.70%,
7/3/28 
1,952,149‌
1,953‌
Icon
Parent,
FRN
3M
TSFR
+
2.75%,
6.44%,
11/13/31 
1,117,692‌
1,070‌
Loire
Finco
Luxembourg,
FRN
1M
TSFR
+
4.00%,
7.668%,
1/21/30 
2,341,773‌
2,335‌
Mariner
Wealth
Advisors,
FRN
3M
TSFR
+
2.25%,
5.95%,
12/31/30 
578,908‌
577‌
Ryan
Specialty,
FRN
1M
TSFR
+
2.00%,
5.668%,
9/15/31 
1,548,588‌
1,545‌
SBA
Senior
Finance
II,
FRN
1M
TSFR
+
1.75%,
5.42%,
1/25/31 
4,015,708‌
4,028‌
Storable,
FRN
1M
TSFR
+
3.25%,
6.918%,
4/16/31 (2)
64,836‌
62‌
TransDigm,
FRN
1M
TSFR
+
2.25%,
5.918%,
3/22/30 
4,356,710‌
4,356‌
TransDigm,
FRN
1M
TSFR
+
2.50%,
6.168%,
2/10/33 
1,039,000‌
1,039‌
UKG,
FRN
3M
TSFR
+
2.50%,
6.167%,
2/10/31 
487,266‌
465‌
USI,
FRN
3M
TSFR
+
2.25%,
5.95%,
11/21/29 
1,326,451‌
1,322‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
2
Par/Shares
$
Value
(Cost
and
value
in
$000s)
USI,
FRN
3M
TSFR
+
2.25%,
5.95%,
9/29/30 
669,839‌
667‌
Varsity
Brands,
FRN
3M
TSFR
+
2.75%,
6.45%,
8/26/31 
1,830,356‌
1,821‌
Total
Bank
Loans
(Cost
$50,846)
50,331‌
COMMON
STOCKS
 42.8%
COMMUNICATION
SERVICES
 3.6%
Entertainment
 0.1%
Netflix (3)
5,778‌
556‌
556‌
Interactive
Media
&
Services
 3.5%
Alphabet,
Class
30,933‌
8,895‌
Meta
Platforms,
Class
8,711‌
4,984‌
13,879‌
Total
Communication
Services
14,435‌
CONSUMER
DISCRETIONARY
 3.9%
Broadline
Retail
 2.2%
Amazon.com (3)
41,434‌
8,629‌
8,629‌
Diversified
Consumer
Services
 0.1%
Service
Corp.
International 
6,116‌
505‌
505‌
Hotels,
Restaurants
&
Leisure
 1.5%
Domino's
Pizza 
1,952‌
700‌
Hilton
Worldwide
Holdings 
3,527‌
1,073‌
McDonald's 
5,928‌
1,842‌
Yum!
Brands 
13,874‌
2,157‌
5,772‌
Household
Durables
 0.1%
TopBuild (3)
1,006‌
353‌
353‌
Total
Consumer
Discretionary
15,259‌
CONSUMER
STAPLES
 1.5%
Consumer
Staples
Distribution
&
Retail
 0.5%
Kroger 
14,612‌
1,057‌
U.S.
Foods
Holding (3)
11,463‌
1,057‌
2,114‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
3
Par/Shares
$
Value
(Cost
and
value
in
$000s)
Household
Products
 0.7%
Colgate-Palmolive 
8,986‌
766‌
Procter
&
Gamble 
13,862‌
2,002‌
2,768‌
Tobacco
 0.3%
Philip
Morris
International 
6,115‌
1,011‌
1,011‌
Total
Consumer
Staples
5,893‌
ENERGY
 1.8%
Energy
Equipment
&
Services
 0.1%
TechnipFMC 
4,939‌
341‌
341‌
Oil,
Gas
&
Consumable
Fuels
 1.7%
Canadian
Natural
Resources 
42,012‌
2,047‌
ConocoPhillips 
4,041‌
533‌
EOG
Resources 
10,331‌
1,494‌
Exxon
Mobil 
16,772‌
2,846‌
6,920‌
Total
Energy
7,261‌
FINANCIALS
 4.5%
Banks
 1.5%
Bank
of
America 
39,771‌
1,939‌
East
West
Bancorp 
5,044‌
539‌
JPMorgan
Chase 
12,012‌
3,533‌
6,011‌
Capital
Markets
 1.6%
Bank
of
New
York
Mellon 
9,577‌
1,136‌
Charles
Schwab 
13,078‌
1,229‌
CME
Group 
4,159‌
1,229‌
Morgan
Stanley 
9,298‌
1,530‌
MSCI 
959‌
517‌
Raymond
James
Financial 
4,786‌
693‌
6,334‌
Financial
Services
 1.3%
Mastercard,
Class
4,648‌
2,322‌
Visa,
Class
10,014‌
3,027‌
5,349‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
4
Par/Shares
$
Value
(Cost
and
value
in
$000s)
Insurance
 0.1%
Willis
Towers
Watson 
1,468‌
427‌
427‌
Total
Financials
18,121‌
HEALTH
CARE
 5.8%
Biotechnology
 1.0%
AbbVie 
5,805‌
1,263‌
Ascendis
Pharma,
ADR (3)
2,545‌
582‌
Cytokinetics (3)
14,679‌
967‌
Gilead
Sciences 
9,525‌
1,328‌
4,140‌
Health
Care
Equipment
&
Supplies
 1.0%
Abbott
Laboratories 
13,948‌
1,432‌
Becton
Dickinson
&
Company 
12,507‌
1,966‌
Stryker 
2,001‌
658‌
4,056‌
Health
Care
Providers
&
Services
 1.3%
Cardinal
Health 
190‌
40‌
Cencora 
4,337‌
1,362‌
Cigna
Group 
1,393‌
372‌
HCA
Healthcare 
1,828‌
865‌
McKesson 
1,261‌
1,091‌
UnitedHealth
Group 
5,501‌
1,489‌
5,219‌
Life
Sciences
Tools
&
Services
 1.2%
Agilent
Technologies 
9,289‌
1,059‌
IQVIA
Holdings (3)
2,924‌
499‌
Mettler-Toledo
International (3)
317‌
400‌
Revvity 
10,678‌
935‌
Thermo
Fisher
Scientific 
1,793‌
881‌
Waters (3)
3,515‌
1,047‌
4,821‌
Pharmaceuticals
 1.3%
Eli
Lilly 
2,789‌
2,565‌
Johnson
&
Johnson 
10,185‌
2,490‌
5,055‌
Total
Health
Care
23,291‌
INDUSTRIALS
&
BUSINESS
SERVICES
 3.2%
Aerospace
&
Defense
 1.0%
General
Dynamics 
3,721‌
1,277‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
5
Par/Shares
$
Value
(Cost
and
value
in
$000s)
General
Electric 
6,624‌
1,880‌
Lockheed
Martin 
1,471‌
889‌
4,046‌
Commercial
Services
&
Supplies
 0.8%
Republic
Services 
5,732‌
1,255‌
Veralto 
10,288‌
910‌
Waste
Management 
3,778‌
868‌
3,033‌
Electrical
Equipment
 0.5%
Acuity 
2,125‌
596‌
AMETEK 
5,199‌
1,114‌
Hubbell 
877‌
430‌
2,140‌
Ground
Transportation
 0.1%
CSX 
13,337‌
547‌
547‌
Machinery
 0.7%
Ingersoll
Rand 
12,970‌
1,039‌
Mueller
Industries 
4,680‌
519‌
Parker-Hannifin 
568‌
508‌
Snap-on 
1,625‌
590‌
2,656‌
Professional
Services
 0.1%
Leidos
Holdings 
3,638‌
566‌
566‌
Total
Industrials
&
Business
Services
12,988‌
INFORMATION
TECHNOLOGY
 13.5%
Communications
Equipment
 0.2%
Motorola
Solutions 
1,497‌
650‌
650‌
Electronic
Equipment,
Instruments
&
Components
 0.4%
TE
Connectivity 
5,929‌
1,239‌
Teledyne
Technologies (3)
578‌
350‌
1,589‌
IT
Services
 0.1%
VeriSign 
1,795‌
446‌
446‌
Semiconductors
&
Semiconductor
Equipment
 6.1%
Advanced
Micro
Devices (3)
10,393‌
2,114‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
6
Par/Shares
$
Value
(Cost
and
value
in
$000s)
Analog
Devices 
2,113‌
672‌
Applied
Materials 
4,344‌
1,485‌
Broadcom 
17,192‌
5,321‌
Lam
Research 
3,301‌
705‌
Micron
Technology 
2,162‌
731‌
NVIDIA 
66,857‌
11,660‌
Taiwan
Semiconductor
Manufacturing,
ADR 
4,391‌
1,484‌
24,172‌
Software
 3.9%
Aurora
Innovation (3)
195,665‌
806‌
Autodesk (3)
1,313‌
314‌
Microsoft 
29,443‌
10,899‌
PTC (3)
10,255‌
1,461‌
Salesforce 
4,570‌
853‌
SAP,
ADR 
3,270‌
560‌
Workday,
Class
A (3)
5,733‌
745‌
15,638‌
Technology
Hardware,
Storage
&
Peripherals
 2.8%
Apple 
43,295‌
10,988‌
10,988‌
Total
Information
Technology
53,483‌
MATERIALS
 0.2%
Metals
&
Mining
 0.2%
Newmont 
4,672‌
506‌
Southern
Copper 
1,982‌
341‌
Total
Materials
847‌
REAL
ESTATE
 0.6%
Industrial
Real
Estate
Investment
Trusts
 0.4%
Prologis,
REIT 
10,760‌
1,422‌
1,422‌
Specialized
Real
Estate
Investment
Trusts
 0.2%
SBA
Communications,
REIT 
5,602‌
964‌
964‌
Total
Real
Estate
2,386‌
UTILITIES
 3.7%
Electric
Utilities
 1.5%
Evergy 
16,395‌
1,343‌
Exelon 
33,367‌
1,636‌
OGE
Energy 
15,732‌
755‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
7
Par/Shares
$
Value
(Cost
and
value
in
$000s)
PPL 
57,258‌
2,187‌
5,921‌
Multi-Utilities
 2.2%
Ameren 
25,604‌
2,814‌
CenterPoint
Energy 
50,944‌
2,199‌
NiSource 
56,707‌
2,646‌
WEC
Energy
Group 
11,232‌
1,300‌
8,959‌
Total
Utilities
14,880‌
Total
Miscellaneous
Common
Stocks
 0.5% (4)
1,892‌
Total
Common
Stocks
(Cost
$153,258)
170,736‌
CONVERTIBLE
PREFERRED
STOCKS
 0.5%
CONSUMER
STAPLES
 0.2%
Beverages
 0.2%
Keurig
Dr
Pepper
PIPE,
Series
A,
Acquisition
Date:
12/24/25,
Cost $1,016 (3)(5)(6)
995‌
995‌
Total
Consumer
Staples
995‌
INFORMATION
TECHNOLOGY
 0.3%
Software
 0.3%
Waymo,
Series
D-2,
Acquisition
Date:
2/2/26,
Cost $1,020 (3)
(5)(6)
6,205‌
1,020‌
Total
Information
Technology
1,020‌
Total
Convertible
Preferred
Stocks
(Cost
$2,036)
2,015‌
CORPORATE
BONDS
 15.4%
American
Tower,
3.80%,
8/15/29 
781,000‌
762‌
American
Tower,
5.90%,
11/15/33 
711,000‌
744‌
AmWINS
Group,
6.375%,
2/15/29 (7)
380,000‌
383‌
Booz
Allen
Hamilton,
3.875%,
9/1/28 (7)
782,000‌
760‌
Booz
Allen
Hamilton,
4.00%,
7/1/29 (7)
419,000‌
405‌
Booz
Allen
Hamilton,
5.95%,
8/4/33 
705,000‌
719‌
Broadcom,
4.15%,
4/15/32 (7)
546,000‌
529‌
Broadstreet
Partners
Group,
5.875%,
4/15/29 (7)
1,532,000‌
1,493‌
CenterPoint
Energy,
VR,
5.95%,
4/1/56 (8)
2,106,000‌
2,080‌
Crown
Castle,
2.25%,
1/15/31 
607,000‌
537‌
Ellucian
Holdings,
6.50%,
12/1/29 (7)
530,000‌
517‌
Fair
Isaac,
6.00%,
5/15/33 (7)
1,753,000‌
1,720‌
Fortive,
4.30%,
6/15/46 
1,213,000‌
971‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
8
Par/Shares
$
Value
(Cost
and
value
in
$000s)
Gartner,
3.625%,
6/15/29 (7)
1,211,000‌
1,137‌
Gartner,
3.75%,
10/1/30 (7)
1,675,000‌
1,530‌
Gartner,
4.50%,
7/1/28 (7)
772,000‌
759‌
Gartner,
5.60%,
11/20/35 
1,149,000‌
1,087‌
Hilton
Domestic
Operating,
3.625%,
2/15/32 (7)
2,817,000‌
2,559‌
Hilton
Domestic
Operating,
4.00%,
5/1/31 (7)
447,000‌
419‌
Hilton
Domestic
Operating,
4.875%,
1/15/30 
385,000‌
379‌
Hilton
Domestic
Operating,
5.50%,
3/31/34 (7)
2,350,000‌
2,296‌
Hilton
Domestic
Operating,
5.75%,
9/15/33 (7)
1,092,000‌
1,089‌
Howmet
Aerospace,
5.95%,
2/1/37 
1,071,000‌
1,141‌
HUB
International,
5.625%,
12/1/29 (7)
1,759,000‌
1,718‌
HUB
International,
7.25%,
6/15/30 (7)
1,647,000‌
1,691‌
IQVIA,
5.70%,
5/15/28 
360,000‌
367‌
IQVIA,
6.50%,
5/15/30 (7)
360,000‌
368‌
Marriott
International,
Series GG,
3.50%,
10/15/32 
991,000‌
911‌
MSCI,
3.25%,
8/15/33 (7)
902,000‌
786‌
MSCI,
3.625%,
9/1/30 (7)
666,000‌
629‌
MSCI,
3.625%,
11/1/31 (7)
527,000‌
488‌
MSCI,
3.875%,
2/15/31 (7)
1,220,000‌
1,155‌
MSCI,
4.00%,
11/15/29 (7)
812,000‌
788‌
NiSource,
VR,
5.75%,
7/15/56 (8)
2,124,000‌
2,088‌
PRA
Health
Sciences,
2.875%,
7/15/26 (7)
400,000‌
396‌
PTC,
4.00%,
2/15/28 (7)
1,667,000‌
1,628‌
SBA
Communications,
3.125%,
2/1/29 
2,935,000‌
2,781‌
Service
Corp.
International,
3.375%,
8/15/30 
266,000‌
246‌
Service
Corp.
International,
4.00%,
5/15/31 
630,000‌
588‌
TransDigm,
4.625%,
1/15/29 
1,270,000‌
1,247‌
TransDigm,
6.125%,
7/31/34 (7)
1,222,000‌
1,204‌
TransDigm,
6.25%,
1/31/34 (7)
105,000‌
106‌
TransDigm,
6.375%,
5/31/33 (7)
829,000‌
827‌
TransDigm,
6.75%,
1/31/34 (7)
955,000‌
968‌
TransDigm,
7.125%,
12/1/31 (7)
719,000‌
743‌
Vail
Resorts,
5.625%,
7/15/30 (7)
191,000‌
190‌
VICI
Properties,
4.125%,
8/15/30 (7)
1,643,000‌
1,574‌
VICI
Properties,
4.625%,
12/1/29 (7)
1,615,000‌
1,588‌
VICI
Properties,
5.125%,
5/15/32 
526,000‌
519‌
Workday,
3.80%,
4/1/32 
1,222,000‌
1,134‌
Yum!
Brands,
3.625%,
3/15/31 
1,356,000‌
1,252‌
Yum!
Brands,
4.625%,
1/31/32 
1,410,000‌
1,347‌
Yum!
Brands,
4.75%,
1/15/30 (7)
1,189,000‌
1,171‌
Yum!
Brands,
5.35%,
11/1/43 
1,325,000‌
1,259‌
Yum!
Brands,
5.375%,
4/1/32 
1,223,000‌
1,213‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
9
Par/Shares
$
Value
(Cost
and
value
in
$000s)
Yum!
Brands,
6.875%,
11/15/37 
691,000‌
752‌
Total
Miscellaneous
Corporate
Bonds
 0.9% (4)
3,574‌
Total
Corporate
Bonds
(Cost
$61,369)
61,312‌
PREFERRED
STOCKS
 0.2%
FINANCIALS
 0.2%
Insurance
 0.2%
AH
Parent,
Series
A,
Acquisition
Date:
9/27/24,
Cost $734 (3)
(5)(6)
745‌
741‌
Total
Financials
741‌
Total
Preferred
Stocks
(Cost
$734)
741‌
U.S.
GOVERNMENT
AGENCY
OBLIGATIONS
(EXCLUDING
MORTGAGE-BACKED)
 24.7%
U.S.
Treasury
Obligations
 24.7%
U.S.
Treasury
Notes,
3.50%,
11/30/30 
441,000‌
433‌
U.S.
Treasury
Notes,
3.625%,
8/31/30 
2,749,000‌
2,715‌
U.S.
Treasury
Notes,
3.625%,
9/30/30 
360,000‌
356‌
U.S.
Treasury
Notes,
3.625%,
10/31/30 
2,033,000‌
2,007‌
U.S.
Treasury
Notes,
3.625%,
12/31/30 
2,034,000‌
2,007‌
U.S.
Treasury
Notes,
3.875%,
4/30/30 
5,941,000‌
5,935‌
U.S.
Treasury
Notes,
3.875%,
6/30/30 
2,121,000‌
2,118‌
U.S.
Treasury
Notes,
3.875%,
7/31/30 
2,537,000‌
2,533‌
U.S.
Treasury
Notes,
3.875%,
8/15/34 
7,059,000‌
6,879‌
U.S.
Treasury
Notes,
4.00%,
3/31/30 
5,127,000‌
5,146‌
U.S.
Treasury
Notes,
4.00%,
5/31/30 
284,000‌
285‌
U.S.
Treasury
Notes,
4.00%,
2/15/34 
14,251,000‌
14,059‌
U.S.
Treasury
Notes,
4.25%,
11/15/34 
11,721,000‌
11,717‌
U.S.
Treasury
Notes,
4.25%,
5/15/35 
13,236,000‌
13,201‌
U.S.
Treasury
Notes,
4.25%,
8/15/35 
14,444,000‌
14,392‌
U.S.
Treasury
Notes,
4.375%,
5/15/34 
10,017,000‌
10,122‌
U.S.
Treasury
Notes,
4.50%,
11/15/33 
826,000‌
843‌
U.S.
Treasury
Notes,
4.625%,
2/15/35 
3,828,000‌
3,927‌
98,675‌
Total
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed)
(Cost
$98,475)
98,675‌
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
10
Par/Shares
$
Value
(Cost
and
value
in
$000s)
SHORT-TERM
INVESTMENTS
 3.3%
Money
Market
Funds
 3.3%
T.
Rowe
Price
Government
Reserve
Fund,
3.71% (9)(10)
13,251,972‌
13,252‌
Total
Short-Term
Investments
(Cost
$13,252)
13,252‌
Total
Investments
in
Securities
 99.5%
(Cost
$379,970)
$
397,062‌
Other
Assets
Less
Liabilities
0.5%
1,872‌
Net
Assets
100.0%
$
398,934‌
Par/Shares
and
Notional
Amount
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
Bank
loan
positions
may
involve
multiple
underlying
tranches.
In
those
instances,
the
position
presented
reflects
the
aggregate
of
those
respective
underlying
tranches
and
the
rate
presented
reflects
the
weighted
average
rate
of
the
settled
positions.
(2)
All
or
a
portion
of
this
loan
is
unsettled
as
of
March
31,
2026.
The
interest
rate
for
unsettled
loans
will
be
determined
upon
settlement
after
period
end.
(3)
Non-income
producing
(4)
The
identity
of
certain
securities
has
been
concealed
to
protect
the
fund
while
it
completes
a
purchase
or
selling
program
for
the
securities.
(5)
Level
3
in
fair
value
hierarchy.
(6)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$2,756
and
represents
0.7%
of
net
assets.
(7)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$33,614
and
represents
8.4%
of
net
assets.
(8)
Security
is
a
fix-to-float
security,
which
carries
a
fixed
coupon
until
a
certain
date,
upon
which
it
switches
to
a
floating
rate.
Reference
rate
and
spread
are
provided
if
the
rate
is
currently
floating.
(9)
Seven-day
yield
(10)
Affiliated
Companies
1M
TSFR
One
month
term
SOFR
(Secured
overnight
financing
rate)
3M
TSFR
Three
month
term
SOFR
(Secured
overnight
financing
rate)
ADR
American
Depositary
Receipts
FRN
Floating
Rate
Note
OTC
Over-the-counter
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
11
.
.
.
.
.
.
.
.
.
.
PIPE
Private
Investment
in
Public
Equity
REIT
A
domestic
Real
Estate
Investment
Trust
whose
distributions
pass-through
with
original
tax
character
to
the
shareholder
VR
Variable
Rate;
rate
shown
is
effective
rate
at
period-end.
The
rates
for
certain
variable
rate
securities
are
not
based
on
a
published
reference
rate
and
spread
but
are
determined
by
the
issuer
or
agent
and
based
on
current
market
conditions.
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
12
(Amounts
in
000s,
except
for
contracts)
OPTIONS
WRITTEN
 (0.0)%
OTC
Options
Written (0.0)%
Counterparty
Description
Contracts
Notional
Amount
$
Value
Goldman
Sachs
AbbVie,
Call,
6/18/26
@
$260.00
53
1,153
(7‌)
Goldman
Sachs
Johnson
&
Johnson,
Call,
4/17/26
@
$250.00
45
1,100
(16‌)
Goldman
Sachs
Procter
&
Gamble,
Call,
6/18/26
@
$175.00
64
924
(2‌)
JPMorgan
Chase
Exxon
Mobil,
Call,
6/18/26
@
$170.00
76
1,289
(78‌)
JPMorgan
Chase
Philip
Morris
International,
Call,
6/18/26
@
$210.00
51
843
(3‌)
Wells
Fargo
Kroger,
Call,
4/17/26
@
$67.50
84
608
(43‌)
Total
Options
Written
(Premiums
$(90))
$
(149‌)
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
13
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
March
31,
2026.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
3.71%
$
—‌#
$
—‌
$
165‌+
Supplementary
Investment
Schedule
Affiliate
Value
12/31/25
Purchase
Cost
Sales
Cost
Value
3/31/26
T.
Rowe
Price
Government
Reserve
Fund,
3.71%
$
18,574‌
 ¤
 ¤
$
13,252‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$165
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$13,252.
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
Unaudited
Notes
to
Portfolio
of
Investments
14
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc. (the
corporation)
is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act). The
Capital
Appreciation
and
Income
Fund
(the
fund)
is an open-end
management
investment
company
established
by
the
corporation
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus.
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
Eastern
time,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
15
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Debt
securities
are
generally traded
in
the over-the-
counter
(OTC)
market
and
are
valued
at
prices
furnished
by
independent
pricing
services
or
by
broker
dealers
who
make
markets
in
such
securities.
When
valuing
securities,
the
independent
pricing
services
consider
factors
such
as,
but
not
limited
to,
the
yield
or
price
of
bonds
of
comparable
quality,
coupon,
maturity,
and
type,
as
well
as
prices
quoted
by
dealers
who
make
markets
in
such
securities.   
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities.
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
16
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Listed
options,
and
OTC
options
with
a
listed
equivalent,
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
and
exchange-traded
options
on
futures
contracts
are
valued
at
closing
settlement
prices.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
the
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
T.
ROWE
PRICE
Capital
Appreciation
and
Income
Fund
17
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
March
31,
2026
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments): 
OTHER
MATTERS 
Unpredictable environmental,
political,
social
and
economic
events,
including
but
not
limited
to,
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
and
regulatory
developments
(including
trading
and
tariff
arrangements),
and
public
health
epidemics
or
threats,
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
a
fund
invests.
The
extent
and
duration
of
such
events
and
resulting
market
disruptions
cannot
be
predicted.
These
and
other
similar
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-
existing
political,
social,
and
economic
risks.
The
fund’s
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
these
or
such
events.
F1577-054Q1
03/26
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Fixed
Income
Securities
1
$
—‌
$
210,318‌
$
—‌
$
210,318‌
Common
Stocks
170,736‌
—‌
—‌
170,736‌
Convertible
Preferred
Stocks
—‌
—‌
2,015‌
2,015‌
Preferred
Stocks
—‌
—‌
741‌
741‌
Short-Term
Investments
13,252‌
—‌
—‌
13,252‌
Total
$
183,988‌
$
210,318‌
$
2,756‌
$
397,062‌
Liabilities
Options
Written
$
—‌
$
149‌
$
—‌
$
149‌
1
Includes
Bank
Loans,
Corporate
Bonds
and
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed).